Medication Description: Neohaimodez (Neohaemodesum)
Clear yellow liquid.
Neo-gemodez differs from hemodez in the molecular weight of polyvinylpyrrolidone used for its manufacture. Instead of a polymer with a molecular weight of 12,600 + 2,700, polyvinylpyrrolidone with a molecular weight of 8,000 + 2,000 is used in the neogemodesis.
Reducing the molecular weight of the polymer accelerates the excretion of the kidneys from the body and improves the detoxification properties of the drug.
As well as gemodez, neogemodez is administered intravenously.
Indications for use are the same as for hemodez.
Contraindicated in severe cardiovascular insufficiency, cerebral hemorrhage, severe allergies.
Product: in bottles of 100; 200 and 400 ml.
The composition (molecular weight of polyvinylpyrrolidone), action, indications and contraindications for use is similar to neogemodesis, but differs from it by a slightly modified production technology.